Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

Similar articles for PubMed (Select 15977418)

1.

Hypertension pharmacogenomics: current status and future directions.

Johnson JA, Turner ST.

Curr Opin Mol Ther. 2005 Jun;7(3):218-25. Review.

PMID:
15977418
2.

Pharmacogenetics of antihypertensive drug responses.

Schwartz GL, Turner ST.

Am J Pharmacogenomics. 2004;4(3):151-60. Review.

PMID:
15174896
3.

Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges.

Johnson JA, Lima JJ.

Pharmacogenetics. 2003 Sep;13(9):525-34. Review.

PMID:
12972951
4.

Pharmacogenetics of antihypertensive treatment.

Arnett DK, Claas SA, Glasser SP.

Vascul Pharmacol. 2006 Feb;44(2):107-18. Epub 2005 Dec 13. Review.

PMID:
16356784
5.

Pharmacogenomics of essential hypertension: are we going the right way?

Filigheddu F, Troffa C, Glorioso N.

Cardiovasc Hematol Agents Med Chem. 2006 Jan;4(1):7-15. Review.

PMID:
16529546
6.

Pharmacogenomics and pharmacogenetics of hypertension: update and perspectives--the adducin paradigm.

Manunta P, Bianchi G.

J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S30-5. Review.

7.

Cardiovascular pharmacogenomics.

Johnson JA, Cavallari LH.

Exp Physiol. 2005 May;90(3):283-9. Epub 2005 Mar 18. Review.

8.

Advancing management of hypertension through pharmacogenomics.

Johnson JA.

Ann Med. 2012 Jun;44 Suppl 1:S17-22. doi: 10.3109/07853890.2011.653399. Review.

9.

Pharmacogenetics of hypertension treatment: a structured review.

Koopmans RP, Insel PA, Michel MC.

Pharmacogenetics. 2003 Dec;13(12):705-13. Review.

PMID:
14646689
10.

Pharmacogenomics of hypertension.

Cadman PE, O'Connor DT.

Curr Opin Nephrol Hypertens. 2003 Jan;12(1):61-70. Review.

PMID:
12496668
11.

Trends in pharmacogenomics of drugs acting on hypertension.

Trotta R, Donati MB, Iacoviello L.

Pharmacol Res. 2004 Apr;49(4):351-6. Review.

PMID:
15202514
12.

Drug target pharmacogenomics: an overview.

Johnson JA.

Am J Pharmacogenomics. 2001;1(4):271-81. Review.

PMID:
12083959
13.

Pharmacogenomics: a new approach to individual therapy of hypertension?

Ferrari P.

Curr Opin Nephrol Hypertens. 1998 Mar;7(2):217-22. Review.

PMID:
9529626
14.

The future of antihypertensive treatment.

Israili ZH, Hernández-Hernández R, Valasco M.

Am J Ther. 2007 Mar-Apr;14(2):121-34. Review.

PMID:
17414579
15.

Cardiovascular pharmacogenomics: current status, future prospects.

Anderson JL, Carlquist JF, Horne BD, Muhlestein JB.

J Cardiovasc Pharmacol Ther. 2003 Mar;8(1):71-83. Review.

PMID:
12652332
16.

Antihypertensive pharmacogenetics: getting the right drug into the right patient.

Turner ST, Schwartz GL, Chapman AB, Hall WD, Boerwinkle E.

J Hypertens. 2001 Jan;19(1):1-11. Review.

PMID:
11204288
17.

Pharmacogenomics of antihypertensive drugs: past, present and future.

Johnson JA.

Pharmacogenomics. 2010 Apr;11(4):487-91. doi: 10.2217/pgs.10.34.

18.

[Individual sensitivity to antihypertensive drugs: genetic aspects].

Minushkina LO, Zateĭshchikov DA, Sidorenko BA.

Kardiologiia. 2005;45(7):58-65. Review. Russian.

PMID:
16091664
19.

Pharmacogenetics of beta1-adrenergic receptors in heart failure and hypertension.

Mialet-Perez J, Liggett SB.

Arch Mal Coeur Vaiss. 2006 Jun;99(6):616-20. Review.

PMID:
16878723
20.

The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.

Schelleman H, Klungel OH, Witteman JC, Hofman A, van Duijn CM, de Boer A, Stricker BH.

Eur J Hum Genet. 2006 Jul;14(7):860-6. Epub 2006 May 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk